Alnylam Pharmaceuticals Inc (ALNY) — Cash Flow Quality Index
Alnylam Pharmaceuticals Inc (ALNY) has a Cash Flow Quality Index of 0.88x as of December 2025. Operating cash flow of $163.56 Million is below net income of $186.42 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Alnylam Pharmaceuticals Inc cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Alnylam Pharmaceuticals Inc Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Alnylam Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ALNY capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Alnylam Pharmaceuticals Inc (2025–2025)
Year-by-year earnings quality comparison for Alnylam Pharmaceuticals Inc. For live market cap and the full company financial profile, see ALNY market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.67x | $524.08 Million | $313.75 Million | — |